No Unauthorized Disclosure of Confidential Information. Beginning on the Effective Date and continuing throughout the term of this Agreement and thereafter for a period of five (5) years (“Confidentiality Period”), neither Party shall disclose or otherwise make known or available to any Third Party or Affiliate any Confidential Information, without the express prior written consent of the other. In no event shall either Party incorporate or otherwise use Confidential Information in connection with any patent application filed by or on behalf of the other. Both Parties shall utilize reasonable procedures to safeguard the Confidential Information.
Appears in 3 contracts
Samples: Non Exclusive Patent License Agreement, Patent License Agreement (GenMark Diagnostics, Inc.), Patent License Agreement (GenMark Diagnostics, Inc.)
No Unauthorized Disclosure of Confidential Information. Beginning on the Effective Date and continuing throughout the term of this Agreement and thereafter for a period of five (5) years (“Confidentiality Period”)5 years, neither receiving Party shall not disclose or otherwise make known or available to any Third Party or Affiliate any disclosing Party Confidential Information, without the express prior written consent of disclosing Party. Notwithstanding the other. In no event foregoing, receiving Party shall either be permitted to disclose disclosing Party incorporate or otherwise use Confidential Information in connection with any patent application filed by or on behalf of the other. Both Parties shall utilize reasonable procedures to safeguard the Confidential Information.to
Appears in 2 contracts
Samples: Non Exclusive Patent License Agreement (HyperSciences, Inc.), Patent License Agreement (HyperSciences, Inc.)
No Unauthorized Disclosure of Confidential Information. Beginning on the Effective Date and continuing throughout the term of this Agreement and thereafter for a period of five (5) years (“Confidentiality Period”)5 years, neither receiving Party shall will not disclose or otherwise make known or available to any Third Party or Affiliate any disclosing Party Confidential Information, without the express prior written consent of the otherdisclosing Party. In no event shall either Receiving Party incorporate or otherwise will use Confidential Information in connection with any patent application filed by or on behalf of the other. Both Parties shall utilize reasonable procedures to safeguard the disclosing Party’s Confidential Information.
Appears in 1 contract
Samples: Exclusive Option Agreement